Cytoreductive nephrectomy for metastatic renal cell carcinoma: inequities in access exist despite improved survival-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cytoreductive nephrectomy for metastatic renal cell carcinoma: inequities in access exist despite improved survival

Published:2017-08-22 Issue:10 Volume:6 Page:2188-2193
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Patel Manish I.¹²^ORCID,Beattie Kieran²,Bang Albert³,Gurney Howard⁴,Smith David P.³⁵⁶

Affiliation:

1. Discipline of Surgery; Westmead Hospital; University of Sydney; Sydney Australia

2. Department of Urology; Westmead Hospital; Westmead Australia

3. Cancer Research Division; Cancer Council NSW; Sydney Australia

4. Faculty of Medicine and Health Sciences; Macquarie University; Sydney Australia

5. Sydney Medical School; The University of Sydney; Sydney Australia

6. Menzies Health Institute Queensland; Griffith University; Nathan Australia

Funder

Cancer Institute NSW

National Health and Medical Research Council

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Reference23 articles.

1. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma;Motzer;J. Clin. Oncol.,2004

2. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer;Flanigan;N. Engl. J. Med.,2001

3. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial;Mickisch;Lancet,2001

4. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N. Engl. J. Med.,2007

5. Survival analyses of metastatic renal cancer patients treated with targeted therapy with or without cytoreductive nephrectomy: a national cancer data base study;Hanna;J. Clin. Oncol.,2016

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytoreductive nephrectomy in metastatic renal cell carcinoma;Cochrane Database of Systematic Reviews;2024-06-07

2. Development of a Nomogram Model to Identify Appropriate Candidates from Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Based on the Surveillance, Epidemiology and End Results Database;Clinical Genitourinary Cancer;2024-06

3. Patients with metastatic renal cell carcinoma who receive immune-targeted therapy may derive survival benefit from nephrectomy;BMC Cancer;2023-10-06

4. Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC;Nature Reviews Urology;2023-07-03

5. Do patients with metastatic renal cell carcinoma obtain survival benefits from cytoreductive nephrectomy? A population-based study;Journal of Cancer Research and Clinical Oncology;2023-05-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3